Observational analysis reveals synergistic cell death in KMT2Ar AML with menin inhibition and MYC degradation, suggesting resistance mechanisms may be overcome.
Key Points
Combined treatment induced over 99% cell death in MOLM-13 cells with significant synergy observed.
The combination was effective against KMT2Ar AML, reducing the protein levels of c-MYC and MCL-1 substantially.
Observational research involved using quantitative PCR and Annexin V/DAPI to assess cell death and transcriptional changes.
Findings support the potential for novel therapies targeting MYC and MCL-1 in acute leukemia treatment.